Patten Group, Inc. Abbott Laboratories Transaction History

Patten Group, Inc.

$440 Million
Q3 2024

A detailed history of Patten Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Patten Group, Inc. holds 7,741 shares of ABT stock, worth $911,580. This represents 0.2% of its overall portfolio holdings.

Number of Shares

7,741

Previous 7,322 5.72%

Holding current value

$911,580

Previous $760,000 16.05%

% of portfolio

0.2%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$100.07 - $118.13 $41,929 - $49,496	419 Added 5.72%	7,741 $882,000
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $25,887 - $28,897	-257 Reduced 3.39%	7,322 $760,000
Q1 2024 Apr 17, 2024	SELL	$109.52 - $120.96 $219 - $241	-2 Reduced 0.03%	7,579 $861,000
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $24,261 - $29,697	-269 Reduced 3.43%	7,581 $834,000
Q3 2023 Oct 12, 2023	BUY	$95.53 - $114.62 $4,489 - $5,387	47 Added 0.6%	7,850 $760,000
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $32,048 - $35,708	-318 Reduced 3.92%	7,803 $850,000
Q1 2023 Apr 06, 2023	BUY	$96.86 - $114.01 $41,746 - $49,138	431 Added 5.6%	8,121 $822,000
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $90,592 - $106,278	-953 Reduced 11.03%	7,690 $844,000
Q3 2022 Oct 13, 2022	SELL	$96.76 - $112.03 $182,682 - $211,512	-1,888 Reduced 17.93%	8,643 $880,000
Q2 2022 Jul 18, 2022	SELL	$102.07 - $123.37 $8,471 - $10,239	-83 Reduced 0.78%	10,531 $1.15 Million
Q1 2022 Apr 28, 2022	BUY	$114.02 - $139.04 $80,156 - $97,745	703 Added 7.09%	10,614 $1.26 Million
Q4 2021 Jan 20, 2022	BUY	$115.53 - $141.46 $111,717 - $136,791	967 Added 10.81%	9,911 $1.4 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $71,045 - $78,597	609 Added 7.31%	8,944 $1.06 Million
Q2 2021 Aug 03, 2021	BUY	$105.79 - $124.53 $207,454 - $244,203	1,961 Added 30.77%	8,335 $966,000
Q1 2021 Apr 23, 2021	BUY	$108.84 - $128.23 $7,074 - $8,334	65 Added 1.03%	6,374 $764,000
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $18,480 - $20,137	176 Added 2.87%	6,309 $691,000
Q3 2020 Oct 19, 2020	BUY	$91.64 - $111.29 $46,278 - $56,201	505 Added 8.97%	6,133 $667,000
Q2 2020 Jul 20, 2020	SELL	$76.57 - $98.0 $33,154 - $42,434	-433 Reduced 7.14%	5,628 $515,000
Q1 2020 Apr 16, 2020	BUY	$62.82 - $91.86 $193,799 - $283,388	3,085 Added 103.66%	6,061 $478,000
Q4 2019 Jan 14, 2020	BUY	$78.51 - $87.4 $18,449 - $20,539	235 Added 8.57%	2,976 $258,000
Q3 2019 Oct 22, 2019	BUY	$81.84 - $88.74 $224,323 - $243,236	2,741 New	2,741 $229,000
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $112,441 - $135,941	-1,698 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $15,774 - $17,409	274 Added 19.24%	1,698 $104,000
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $4,026 - $4,310	75 Added 5.56%	1,424 $81,000
Q3 2017 Dec 13, 2017	SELL	$48.06 - $53.64 $5,863 - $6,544	-122 Reduced 8.29%	1,349 $72,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $5,863 - $6,544	122 Added 9.04%	1,471 $72,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,349	1,349 $66,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.

Account